This month, GR Korea continues to share important and noteworthy news from the healthcare sector. In April, the 22nd General Election took a place, and both the ruling and opposition parties met in agreement on bio industry-related pledges, such as increasing R&D investment to foster the domestic biopharma industry. After the general election, the healthcare sector should pay particular attention to whether or not and when these pledges will be implemented.

Please refer to the attached document for detailed insights.